fr

Successful first “Aeson® European User Meeting”, marking an important step in the deployment of CARMAT’s artificial heart

Q&A on CARMAT project

Download

CARMAT obtains regulatory approval to finalize its Clinical Feasibility Study

Download

2015 half-year results in line with the Company's stage of development

Download

The 3rd patient implanted with a CARMAT heart has returned home

Download

Interim results of the feasibility study presented at the ESC Congress in London

Download

CARMAT appoints Benoît de la Motte as CFO

Download

Initial details of the analysis of the CARMAT heart implanted in the second patient

Download

Update on the feasibility study of the first bioprosthetic artificial heart

Download
Top of page